Metabolic Dysfunction–Associated Steatohepatitis Comorbidity Burden and Overall, Waiting-List, and Post–Liver Transplant Mortality

This cohort study examines the comorbidities and long-term outcomes associated with metabolic dysfunction–associated steatohepatitis (MASH) in patients on the liver transplant waiting list.

Corresponding Author: W. Gaya Shivega, MD, Department of Surgery, Division of Abdominal Organ Transplantation, Oregon Health shivega@ohsu.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.